Eaton Vance Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $270K | Buy |
3,369
+19
| +0.6% | +$1.52K | ﹤0.01% | 1452 |
|
2022
Q2 | $321K | Sell |
3,350
-1,149
| -26% | -$110K | ﹤0.01% | 1457 |
|
2022
Q1 | $668K | Sell |
4,499
-36
| -0.8% | -$5.35K | ﹤0.01% | 1454 |
|
2021
Q4 | $643K | Buy |
4,535
+200
| +5% | +$28.4K | ﹤0.01% | 1273 |
|
2021
Q3 | $423K | Buy |
4,335
+32
| +0.7% | +$3.12K | ﹤0.01% | 1241 |
|
2021
Q2 | $591K | Buy |
4,303
+844
| +24% | +$116K | ﹤0.01% | 1309 |
|
2021
Q1 | $452K | Buy |
3,459
+98
| +3% | +$12.8K | ﹤0.01% | 1302 |
|
2020
Q4 | $376K | Hold |
3,361
| – | – | ﹤0.01% | 1277 |
|
2020
Q3 | $264K | Buy |
3,361
+23
| +0.7% | +$1.81K | ﹤0.01% | 1242 |
|
2020
Q2 | $240K | Buy |
+3,338
| New | +$240K | ﹤0.01% | 1232 |
|